标题
Investigational drugs in Alzheimer's disease: current progress
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 23, Issue 6, Pages 837-846
出版商
Informa Healthcare
发表日期
2014-04-05
DOI
10.1517/13543784.2014.905542
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses
- (2017) Noel G. Faux et al. JOURNAL OF ALZHEIMERS DISEASE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Successes and Failures for Drugs in Late-Stage Development for Alzheimer’s Disease
- (2013) Camryn Berk et al. DRUGS & AGING
- Deep brain stimulation in dementia-related disorders
- (2013) Sarah Hescham et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Long-Term Treatment of Thalidomide Ameliorates Amyloid-Like Pathology through Inhibition of β-Secretase in a Mouse Model of Alzheimer’s Disease
- (2013) Ping He et al. PLoS One
- Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy
- (2013) Alireza Atri et al. Alzheimers Research & Therapy
- Increased Cerebral Metabolism After 1 Year of Deep Brain Stimulation in Alzheimer Disease
- (2012) Gwenn S. Smith et al. ARCHIVES OF NEUROLOGY
- Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
- (2012) Vladimir Coric et al. ARCHIVES OF NEUROLOGY
- EHT0202 in Alzheimers Disease: A 3-Month, Randomized, Placebo- Controlled, Double-Blind Study
- (2012) B. Vellas et al. Current Alzheimer Research
- Solanezumab for the treatment of mild-to-moderate Alzheimer’s disease
- (2012) Bruno P Imbimbo et al. Expert Review of Clinical Immunology
- A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer disease
- (2012) Rashid Deane et al. JOURNAL OF CLINICAL INVESTIGATION
- The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice
- (2012) B. Zhang et al. JOURNAL OF NEUROSCIENCE
- An Effector-Reduced Anti- -Amyloid (A ) Antibody with Unique A Binding Properties Promotes Neuroprotection and Glial Engulfment of A
- (2012) O. Adolfsson et al. JOURNAL OF NEUROSCIENCE
- Alzheimer's disease market: hope deferred
- (2012) Zelicia Gerald et al. NATURE REVIEWS DRUG DISCOVERY
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
- (2011) Suzanne Craft ARCHIVES OF NEUROLOGY
- T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic mice
- (2011) Tetsuo Fukushima et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tau elevations in the brain extracellular space correlate with reduced amyloid-β levels and predict adverse clinical outcomes after severe traumatic brain injury
- (2011) Sandra Magnoni et al. BRAIN
- Tau as a Therapeutic Target for Alzheimers Disease
- (2011) A. Boutajangout et al. Current Alzheimer Research
- The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
- (2011) P. L. McClean et al. JOURNAL OF NEUROSCIENCE
- PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease
- (2010) Marwan N. Sabbagh et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Solanezumab was safe and well-tolerated for Asian patients with mild-to-moderate Alzheimer's disease in a multicenter, randomized, open-label, multi-dose study
- (2010) Taro Goto et al. Alzheimers & Dementia
- Epothilone D Improves Microtubule Density, Axonal Integrity, and Cognition in a Transgenic Mouse Model of Tauopathy
- (2010) K. R. Brunden et al. JOURNAL OF NEUROSCIENCE
- RG3487, a Novel Nicotinic 7 Receptor Partial Agonist, Improves Cognition and Sensorimotor Gating in Rodents
- (2010) T. L. Wallace et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
- (2010) Juha O Rinne et al. LANCET NEUROLOGY
- Can Alzheimer disease be prevented by amyloid-β immunotherapy?
- (2010) Cynthia A. Lemere et al. Nature Reviews Neurology
- An update on treatment and prevention strategies for Alzheimer’s disease
- (2009) Judith Neugroschl et al. Current Neurology and Neuroscience Reports
- Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers
- (2009) Fernanda G. De Felice et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nicotinic receptor agonists and antagonists increase sAPPα secretion and decrease Aβ levels in vitro
- (2008) M. Mousavi et al. NEUROCHEMISTRY INTERNATIONAL
- Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways
- (2007) Hani Atamna et al. FASEB JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More